Name
Optimapharm Estonia OÜ
Registry code
12856444
VAT number
EE101798648
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
27.05.2015 (9)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
82991 - Other business support service activities n.e.c.
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Grant Thornton Baltic OÜ 10384467 | - | Contact person | - |
| 2019 30.04.2020 | 2020 16.03.2021 | 2021 28.02.2022 | 2022 01.09.2023 | |
|---|---|---|---|---|
| Total Revenue | 1 138 476 € | 1 127 007 € | 1 506 644 € | 1 181 932 € |
| Net profit (loss) for the period | 36 679 € | 43 327 € | 57 948 € | 43 742 € |
| Profit Margin | 3% | 4% | 4% | 4% |
| Current Assets | 354 955 € | 377 610 € | 424 058 € | 413 439 € |
| Fixed Assets | - | - | - | - |
| Total Assets | 354 955 € | 377 610 € | 424 058 € | 413 439 € |
| Current Liabilities | 187 954 € | 167 282 € | 155 782 € | 101 421 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 167 001 € | 210 328 € | 268 276 € | 312 018 € |
| Employees | 23 | 20 | 25 | 20 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 640 995.26 € | 98 345.42 € | 105 333.29 € | 17 |
| 2023 Q4 | 274 267.94 € | 93 605.67 € | 100 124.66 € | 16 |
| 2023 Q3 | 266 223.82 € | 90 547.57 € | 97 300.64 € | 17 |
| 2023 Q2 | 318 807.62 € | 109 541.92 € | 117 087.98 € | 16 |
| 2023 Q1 | 288 786.21 € | 93 068.61 € | 99 105.98 € | 16 |
| 2022 Q4 | 280 191.23 € | 91 128.27 € | 96 631.97 € | 20 |
| 2022 Q3 | 283 683.75 € | 96 453.6 € | 102 785.9 € | 17 |
| 2022 Q2 | 294 839.94 € | 120 136.98 € | 125 847.13 € | 19 |
| 2022 Q1 | 320 273.18 € | 132 238.23 € | 140 311.66 € | 21 |
| 2021 Q4 | 345 643.71 € | 133 205.73 € | 139 661.89 € | 22 |
| 2021 Q3 | 366 621.69 € | 135 851.51 € | 143 488.63 € | 22 |
| 2021 Q2 | 433 718.96 € | 94 833.73 € | 101 821.64 € | 25 |
| 2021 Q1 | 420 543.24 € | 112 570.89 € | 120 877.09 € | 25 |
| 2020 Q4 | 287 909.09 € | 62 122.74 € | 68 111.27 € | 26 |
| 2020 Q3 | 261 453.56 € | 130 789.78 € | 136 663.63 € | 21 |
| 2020 Q2 | 257 828.45 € | 85 100.36 € | 88 506.55 € | 20 |
| 2020 Q1 | 327 467.89 € | 63 840.59 € | 68 491.28 € | 20 |
